Autologous peripheral blood stem cell transplantation for POEMS syndrome

Neurology

Volumn 66, Issue 1, 2006, Pages 105-107

  Kuwabara, S ^a,b   Misawa, S ^a   Kanai, K ^a   Kikkawa, Y ^a   Nishimura, M ^a   Nakaseko, C ^a   Cho, R K ^a   Hattori, T ^a  

^a CHIBA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b CHIBA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHOSPHAMIDE; GRANULOCYTE COLONY STIMULATING FACTOR; M PROTEIN; MELPHALAN; VASCULOTROPIN; MYELOABLATIVE AGENT; VASCULOTROPIN A;

ADULT; AGED; ARTICLE; AUTOLOGOUS PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; BLOOD LEVEL; CLINICAL ARTICLE; DRUG MEGADOSE; ENDOCRINE DISEASE; FEMALE; HUMAN; MALE; PARAPROTEINEMIA; PLASMACYTOMA; POLYNEUROPATHY; PRIORITY JOURNAL; RARE DISEASE; SKIN DISEASE; SYMPTOMATOLOGY; SYSTEMIC DISEASE; TREATMENT INDICATION; TREATMENT OUTCOME; AUTOTRANSPLANTATION; BLOOD; CLINICAL TRIAL; COMPARATIVE STUDY; DOWN REGULATION; DRUG EFFECT; HEMATOPOIETIC STEM CELL TRANSPLANTATION; METABOLISM; METHODOLOGY; MIDDLE AGED; PATHOPHYSIOLOGY; PERIPHERAL NEUROPATHY; PHYSIOLOGY; SECRETION;

ADULT; AGED; DOWN-REGULATION; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; MALE; MELPHALAN; MIDDLE AGED; MYELOABLATIVE AGONISTS; PERIPHERAL NERVOUS SYSTEM DISEASES; PLASMACYTOMA; POEMS SYNDROME; TRANSPLANTATION, AUTOLOGOUS; TREATMENT OUTCOME; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 33645799287     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/01.wnl.0000188757.38495.23     Document Type: Article

References (10)

1. Bardwick PA, Zvaifler NJ, Newman GD, Greenway GD, Resnick DL. Plasma cell dyscrasia with polyneuropathy, organomegaly, endocrinopathy, M-protein, and skin changes: the POEMS syndrome. Report of two cases and a review of the literature. Medicine 1980;59:311-322.
2. Nakanishi T, Sobue I, Toyokura Y, et al. The Crow-Fukase syndrome: a study of 112 cases in Japan. Neurology 1984;34:712-720.
3. Miralles GD, O'Fallon JR, Talley NJ. Plasma cell dyscrasia with polyneuropathy. The spectrum of POEMS syndrome. N Engl J Med 1992;327:1919-1923.
4. Kuwabara S, Hattori T, Shimoe Y, Kamitsukasa I. Long term melphalan-predonisolone chemotherapy for POEMS syndrome. J Neurol Neurosurg Psychiatry 1997;63:385-387.
5. Watanabe O, Arimura K, Kitajima I, Osame M, Maruyama K. Greatly raised vascular endothelial growth factor (VEGF) in POEMS syndrome. Lancet 1996;347:702.
6. Dispenzieri A, Kyle R, Lacy MQ, et al. POEMS syndrome: definitions and long-term prognosis. Blood 2003;101:2496-2506.
7. Jaccard A, Royer B, Brouel J-C, Fermand J-P. High-dose therapy and autologous blood stem cell transplantation in POEMS syndrome. Blood 2002;99:3057-3059.
8. Rovira M, Carreras E, Blade J, et al. Dramatic improvement of POEMS syndrome following autologous haematopoietic cell transplantation. Br J Haematol 2001;115:373-375.
9. Dispenzieri A, Moreno-Aspitia A, Suarez GA, et al. Peripheral blood stem cell transplantation in 16 patients with POEMS syndrome, and a review of the literature. Blood 2004;104:3400-3407.
10. Badros A, Porter N, Zimrin A. Bevacizumab therapy for POEMS syndrome. Blood 2005;106:1135.